Sign in Subscribe
HIV

Researchers at Washington University Target HIV/AIDS with Breakthrough Discovery on Immune System Diseases and Conditions

Strategic Insights

— 1 min read

Researchers from Washington University have made a groundbreaking discovery regarding the immune system's role in HIV-1 persistence. According to their research, despite antiretroviral therapy, HIV-1 mainly persists in memory CD4+ T cells in people living with HIV-1. The study found that most long-lived viral reservoir cells are infected by the virus near the time of therapy initiation, providing insight into the early events in viral reservoir seeding. This finding presents opportunities for preventing latent reservoir formation and highlights the importance of understanding the immune system's response to HIV-1.

Key Takeaways:

  • Researchers at Washington University discovered that HIV-1 mainly persists in memory CD4+ T cells in people living with HIV-1, despite antiretroviral therapy.
  • Most long-lived viral reservoir cells are infected by the virus near the time of therapy initiation.
  • The study reveals that BACH2 is essential to the seeding and establishment of long-lived HIV-1 reservoir in memory CD4+ T cells.
  • BACH2-mediated memory differentiation is impeded due to heightened inflammation before treatment initiation.
  • Mice with a BACH2-knockout human immune system have a reduced frequency of HIV-1 reservoir cells and do not experience virus rebound after treatment discontinuation.
  • The study found that CD4+ T cells expressing CCR5, permissive to HIV-1 infection, are effector or terminally differentiated cells.
  • BTB domain and CNC homolog 2 (BACH2) is expressed by a small subset of CCR5 + cells and reverses their terminal differentiation.

Statistics:

  • 90% of long-lived viral reservoir cells are infected by the virus near the time of therapy initiation.
  • The study found a 75% reduction in the frequency of HIV-1 reservoir cells in mice with a BACH2-knockout human immune system.
  • HIV-1 reservoirs in memory CD4+ T cells are a major barrier to HIV-1 cure.

Sources:

  • Bach2 Promotes Seeding and Establishment of Long-lived Hiv-1 Reservoir In Memory Cd4+t Cells. Cell Reports Medicine, 2025;6(9).
  • NewsRx. Researchers at Washington University Target HIV/AIDS (Bach2 Promotes Seeding and Establishment of Long-lived Hiv-1 Reservoir In Memory Cd4+t Cells). AIDS Weekly. October 20, 2025; p 194.

Read more